UNSPSC 51151641: Fentonium

This classification denotes an antimuscarinic agent with the molecular formula C31H34NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 26BF4S8FO5. European Medicines Agency schedules fentonium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02132MIG. FENTONIUM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, FENTONIUM remains the US FDA Preferred Term for this commodity.

Fentonium bears US NLM identifiers UMLS ID C0060206 and NCI Concept Code C83712. SMILES: C[N+]1(C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3)CC(=O)C4=CC=C(C=C4)C5=CC=CC=C5.[Br-].

UNSPSC 51151641 Fentonium is a Commodity code, but the recent state and local opportunities tagged under it show little alignment with the code's nominal scope. The two recent solicitations — Seminole County, Florida's IFB for naloxone and drug deactivation systems (posted June 30, 2026, due July 26, 2023), and the Texas Health and Human Services Commission's RFI regarding direct-to-manufacturer prescription programs (posted April 3, 2026) — involve pharmaceutical products and healthcare distribution, not fentonium specifically. The naloxone procurement targets community health initiatives with quarterly deliveries of 1,900 units of naloxone and 800 safe drug deactivation systems annually; the Texas RFI explores vendor capacity to establish direct relationships between state pharmacy benefit programs and pharmaceutical manufacturers, outside traditional pharmacy benefit manager and group purchasing organization channels. Neither opportunity reflects the stated commodity classification.

The issuing bodies are a county health authority and a state HHS agency. Geographic activity is limited to Florida and Texas based on these records. The Seminole County solicitation is an IFB with a response deadline of July 26, 2023 (note: the posted date of June 30, 2026 conflicts with the deadline year, suggesting a data-entry inconsistency in the source). The Texas HHS Commission RFI, posted April 3, 2026, with a response deadline of April 3, 2026, serves as a preliminary market-intelligence vehicle to inform future formal procurement strategy rather than a binding solicitation. The code shows minimal relevant recent activity; buyers pursuing fentonium contracts should verify that opportunities tagged under this code actually match their product or service lines, as misclassification appears common in this taxonomy entry.